Amlexin™: Let’s talk about Cartilage Protection

Be the first to bring Amlexin™ to the European market: This unique, natural, plant-based formulation is a proprietary blend of Acacia catechu heartwood extract and Morus alba root bark extract. Clinical trials with human subjects have revealed its safety and potential in protecting cartilage from breaking down.

In the joint health market, there are numerous options, but only few focus on protecting cartilage from damage. According to research, AmLexin™ stands out for being effective in reducing Glycosaminoglycan (GAG) released by articular cartilage. There is more… clinical studies have also shown its effectiveness.

During a 12-week study, 135 participants (aged 35 to 75 years) experiencing knee discomfort were supplemented with 400mg/day of AmLexin™.1

Results showed that participants in the AmLexin™ group experienced an 8.9% reduction in uCTX-II levels. Urinary cross-linked C-terminal telopeptide of type II collagen (uCTX-II) is a biomarker of type II collagen associated with joint cartilage breakdown. Other clinical trials further validate its efficacy.

To explore further, visit our AmLexin™ dedicated page or contact us. Book a meeting with the team at our Vitafoods 2024 Stand (D80).


(1) Kalman DS, Hewlings SJ. The Effects of Morus albaand Acacia catechuon Quality of Life and Overall Function in Adults with Osteoarthritis of the Knee. J Nutr Metab. 2017;2017:4893104. doi: 10.1155/2017/4893104. Epub 2017 Sep 11. PMID: 29085676; PMCID: PMC5612321